3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases

This invention provides compounds of Formula (Ia): wherein: R 1 has various meanings including C 1-6 alkyl, CN, CO 2 R 5 , C(O)R 5 , C 2-6 alkenyl, C 3-8 cycloalkenyl, C 2-6 alkynyl, NR 5 R 6 , C(O)NR 5 R 6 , phenyl, thiophene, C 1-3 alkoxy, halogen and S(O) k R 5 ; R 2 is heteroaryl, substituted wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HANSSON, TOMAS, HEDEMYR, ANNABEL L. OLSEN, ULLRICH, JOHN W, CHENG, AIPING, MILLER, CHRISTOPHER, P, UNWALLA, RAYOMAND, J, RHOENNSTAD, PATRIK, P, STEFFAN, ROBERT J, BOWEN, STEPHEN, M, KRUGER, LARS, MATELAN, EDWARD, M, ZAMARATSKI, EDOUARD, WROBEL, JAY, E
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention provides compounds of Formula (Ia): wherein: R 1 has various meanings including C 1-6 alkyl, CN, CO 2 R 5 , C(O)R 5 , C 2-6 alkenyl, C 3-8 cycloalkenyl, C 2-6 alkynyl, NR 5 R 6 , C(O)NR 5 R 6 , phenyl, thiophene, C 1-3 alkoxy, halogen and S(O) k R 5 ; R 2 is heteroaryl, substituted with YD; or R 2 is phenyl substituted with up to four substituents YD; R 20 is H or C 1-3 alkyl; and R 4 is H, halogen, methyl or methoxy; and pharmaceutically acceptable salts thereof. The compounds and salts are useful in the treatment or inhibition of Liver X Receptor (LXR) mediated diseases.